For p-mTOR expression, the 5-year overall survival rates in NPC patients with high expression (n = 109) was 55%, and was 62% for patients with low expression (n = 114), with no significant difference between the two groups (p = 0.311, Figure 6B). Here, MTOR is linked to nasopharyngeal carcinoma.